{{Rsnum
|rsid=1408077
|Gene=CR1
|Chromosome=1
|position=207630796
|Orientation=minus
|GMAF=0.1855
|Gene_s=CR1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}
{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 59.3 | 31.0 | 9.7
| HCB | 43.4 | 44.1 | 12.5
| JPT | 49.6 | 38.1 | 12.4
| YRI | 92.5 | 7.5 | 0.0
| ASW | 71.9 | 28.1 | 0.0
| CHB | 43.4 | 44.1 | 12.5
| CHD | 45.9 | 41.3 | 12.8
| GIH | 89.1 | 9.9 | 1.0
| LWK | 85.5 | 13.6 | 0.9
| MEX | 75.9 | 24.1 | 0.0
| MKK | 63.2 | 32.3 | 4.5
| TSI | 62.7 | 34.3 | 2.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=21459483
|Title=Using CSF biomarkers to replicate genetic associations in Alzheimer's disease
|OA=1
}}

{{PMID Auto
|PMID=19734902
|Title=Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease.
|OA=1
}}

{{PMID Auto
|PMID=19898621
|Title=Gemcitabine and arabinosylcytosin pharmacogenomics: genome-wide association and drug response biomarkers.
|OA=1
}}

{{PMID Auto
|PMID=21379329
|Title=Genome-wide association of familial late-onset Alzheimer's disease replicates BIN1 and CLU and nominates CUGBP2 in interaction with APOE.
|OA=1
}}

{{PMID Auto
|PMID=23180304
|Title=Genetic risk score predicting accelerated progression from mild cognitive impairment to Alzheimer's disease.
}}

{{PMID Auto
|PMID=20558387
|Title=Genetic variation and neuroimaging measures in Alzheimer disease.
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}